Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
LUMISIGHT (PEGULICIANINE ACETATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
LUMISIGHT
NDA
Get alerts
PEGULICIANINE ACETATE | N214511 | LUMICELL INC
1 strength
6 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
6 unique patents, 1 exclusivity by expiration date
Active (6)
Today
Exclusivity
2027
2028
2029
2030
2031
2032
2033
2034
2035
Today
9032965
Dec. 8, 2031
9155471
Oct. 12, 2031
9532835
Dec. 8, 2031
9763577
Sep. 14, 2034
10285759
Dec. 8, 2031
11592396
Sep. 1, 2030
NCE
Apr. 17, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 39MG BASE/VIAL
RLD
6 patents
1 exclusivity
▴
POWDER;INTRAVENOUS | Approved: Apr 17, 2024
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9032965
Dec 8, 2031
—
—
—
U-3890
A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS
—
9155471
Oct 12, 2031
—
—
—
U-3890
A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS
—
9532835
Dec 8, 2031
—
—
—
U-3890
A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS
—
9763577
Sep 14, 2034
—
Yes
Yes
U-3890
A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS
—
10285759
Dec 8, 2031
—
—
—
U-3890
A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS
—
11592396
Sep 1, 2030
—
Yes
—
—
—
Exclusivities (1)
Code
Date
Status
NCE
Apr 17, 2029
Active